Biogen & Genentech, Inc.
Verified Pharmaceutical Manufacturer & Oncology Drug Supplier
Biogen & Genentech, Inc.
Verified PartnerRegistered pharmaceutical manufacturer and healthcare technology supplier listed on the ONC-ORG national directory.
Company Profile & Registration
Legal Organization NameBiogen & Genentech, Inc.
Manufacturer Identification CodeRegistered
Authorized RepresentativeCorporate Representative
Compliance & StatusActive / Listed
Oncology Drugs & Clinical Formulations
Featured Drug Formulation
View Complete Drug Profile Rituxan
Generic: rituximab
Class: CD20 / CD38 Targeted Cytolytic Antibody
Indications: Non-Hodgkin lymphoma (diffuse large B-cell, follicular), chronic lymphocytic leukemia in combination with fludarabine and cyclophosphamide, and granulomatosis with polyangiitis.
Direct Communication & Assistance
Send an Inquiry to Biogen & Genentech, Inc.
Our oncology navigation desk will route your inquiry regarding medicine access, clinical partnerships, or product availability to the appropriate representative.
